You are here

New Data Increase Interest in Locoregional Cancer Therapies

Professor Chris Verslype, MD, PhD, an oncology/hepatology specialist in Belgium, discusses data that are raising interest in logoregional therapies for hepatocellular carcinoma and metastatic colon cancer. These options include PV-10, selective internal radiation therapy, and radiofrequency ablation.  

ESMO World Congress on Gastrointestinal Cancer, July 2015